The group’s Indian arm, Meyer Vitabiotics, accounts for around 20% of the total Rs 3,000 crore (£253 million) in annual sales. Within Meyer’s portfolio, Calcimax holds a strong presence across paediatrics, diabetes, cardiac care, and women’s health segments, particularly in pregnancy and menopause.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/wo7O2pS
via gqrds
No comments:
Post a Comment